What does the Vectra report show?Vectra categorizes RA disease activity into low, moderate, or high disease activity. An initial Vectra score provides an objective, quantitative starting point to track RA disease activity over time with subsequent testing.
Vectra Score factors in age, gender and adiposity of the patient to inform better treatment decisions.
Change in Score will show the difference between multiple scores and indicate if there has been a meaningful change, or no change in disease activity.
Vectra Score Interpretation provides a more detailed explanation of the Vectra Score, disease activity category, risk of radiographic progression and treatment plan consideration.
Vectra Scores Over Time is a rolling 3.5 year date range plus initial score consisting of 7 half-year periods.
As of 12/4/2017 Vectra Score has been adjusted based on age, gender and adiposity of the patient.
Meaningful Change is the smallest absolute change in the Vectra Score that is likely to reflect change in disease activity.
The Vectra Score is calculated from the concentrations of the 12 biomarkers shown on this page, which represent different biological pathways involved in RA pathophysiology. The clinical interpretation of individual biomarker values, which have different weights in the Vectra algorithm, has not been estiblished.
Includes the leptin range for all RA patients.
Result/Units: Concentration of the individual biomarkers.
The RA range refers to the reference range for each biomarker based on a reference set of RA patients. This is the concentration range that contains for the central 95% of results for that biomarker.
Patient biomarker level relative to all levels in all patients in the RA reference set.